Application of machine learning in the diagnosis of axial spondyloarthritis.


Journal

Current opinion in rheumatology
ISSN: 1531-6963
Titre abrégé: Curr Opin Rheumatol
Pays: United States
ID NLM: 9000851

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 30 4 2019
medline: 6 5 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

In this review article, we describe the development and application of machine-learning models in the field of rheumatology to improve the detection and diagnosis rates of underdiagnosed rheumatologic conditions, such as ankylosing spondylitis and axial spondyloarthritis (axSpA). In an attempt to aid in the earlier diagnosis of axSpA, we developed machine-learning models to predict a diagnosis of ankylosing spondylitis and axSpA using administrative claims and electronic medical record data. Machine-learning algorithms based on medical claims data predicted the diagnosis of ankylosing spondylitis better than a model developed based on clinical characteristics of ankylosing spondylitis. With additional clinical data, machine-learning algorithms developed using electronic medical records identified patients with axSpA with 82.6-91.8% accuracy. These two algorithms have helped us understand potential opportunities and challenges associated with each data set and with different analytic approaches. Efforts to refine and validate these machine-learning models are ongoing. We discuss the challenges and benefits of machine-learning models in healthcare, along with potential opportunities for its application in the field of rheumatology, particularly in the early diagnosis of axSpA and ankylosing spondylitis.

Identifiants

pubmed: 31033569
doi: 10.1097/BOR.0000000000000612
pmc: PMC6553337
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

362-367

Références

Arthritis Rheumatol. 2018 May;70(5):690-701
pubmed: 29468833
J Clin Rheumatol. 2017 Oct;23(7):383-391
pubmed: 28937474
Clin Rheumatol. 2020 Apr;39(4):975-982
pubmed: 31044386
Lancet. 2018 Mar 31;391(10127):1249-1250
pubmed: 29619949
Arthritis Care Res (Hoboken). 2017 Sep;69(9):1414-1420
pubmed: 27813310
Clin Immunol. 2018 Jan;186:87-93
pubmed: 28811201
JAMA. 2016 Dec 13;316(22):2402-2410
pubmed: 27898976
J Comp Eff Res. 2018 Apr;7(4):369-380
pubmed: 29148281
Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii3-7
pubmed: 12381505
Clin Exp Rheumatol. 2012 Mar-Apr;30(2):246-53
pubmed: 22409861
Curr Opin Rheumatol. 2018 Mar;30(2):137-143
pubmed: 29227352
Nat Rev Rheumatol. 2012 Apr 10;8(5):262-8
pubmed: 22487797
Best Pract Res Clin Rheumatol. 2014 Oct;28(5):663-72
pubmed: 25488776
Ann Rheum Dis. 2005 May;64(5):659-63
pubmed: 15528281
Arthritis Rheum. 2007 Jan;56(1):234-43
pubmed: 17195227
Lancet. 2007 Apr 21;369(9570):1379-1390
pubmed: 17448825
Autoimmun Rev. 2017 Sep;16(9):911-924
pubmed: 28705780
Am Fam Physician. 2015 May 15;91(10):708-14
pubmed: 25978200
Inflamm Bowel Dis. 2017 Dec 19;24(1):45-53
pubmed: 29272474
Clin Rheumatol. 2009 Nov;28(11):1309-14
pubmed: 19685294
Int J Rheum Dis. 2012 Apr;15(2):163-8
pubmed: 22462419
Rheumatology (Oxford). 2009 Jun;48(6):626-31
pubmed: 19389822
Arthritis Care Res (Hoboken). 2012 May;64(5):658-67
pubmed: 22231904
Pain Manag Nurs. 2018 Feb;19(1):14-22
pubmed: 29422123
Arthritis Rheum. 2013 Oct;65(10):2645-54
pubmed: 23818109
Clin Rheumatol. 2017 Oct;36(10):2359-2364
pubmed: 28780639
Rheumatology (Oxford). 2018 Aug 1;57(suppl_6):vi29-vi34
pubmed: 30445484
Rheumatol Ther. 2019 Jun;6(2):255-267
pubmed: 31041666
Arthritis Rheum. 2005 Apr;52(4):1000-8
pubmed: 15818678
N Engl J Med. 2016 Jun 30;374(26):2563-74
pubmed: 27355535
PLoS One. 2013 Aug 16;8(8):e69932
pubmed: 23976944
Clin Rheumatol. 2016 Jul;35(7):1769-76
pubmed: 26987341
Arthritis Res Ther. 2005;7(3):R513-25
pubmed: 15899038
Nat Clin Pract Rheumatol. 2006 Oct;2(10):546-53
pubmed: 17016480
Ann Rheum Dis. 2009 Jun;68(6):777-83
pubmed: 19297344
PLoS Med. 2018 Dec 31;15(12):e1002721
pubmed: 30596635
Rheum Dis Clin North Am. 2012 May;38(2):387-403
pubmed: 22819091
Ann Rheum Dis. 2011 Jan;70(1):25-31
pubmed: 21109520
J Health Organ Manag. 2008;22(6):627-41
pubmed: 19579575
Ann Intern Med. 2007 Oct 2;147(7):478-91
pubmed: 17909209
PLoS One. 2018 Feb 8;13(2):e0192524
pubmed: 29420599
J Bioeth Inq. 2017 Dec;14(4):501-513
pubmed: 28983835
JAMA Netw Open. 2018 Aug 3;1(4):e181404
pubmed: 30646089
J Rheumatol. 2000 Mar;27(3):613-22
pubmed: 10743798
Clin Rev Allergy Immunol. 2018 Dec;55(3):332-339
pubmed: 28779298
Rheumatology (Oxford). 2012 Feb;51(2):333-7
pubmed: 22087013
Am J Med Sci. 2013 Jun;345(6):431-6
pubmed: 23841117
J Rheumatol. 2019 Nov;46(11):1450-1457
pubmed: 30647189
Sci Rep. 2017 Aug 31;7(1):10189
pubmed: 28860558
JAMA Intern Med. 2018 Nov 1;178(11):1544-1547
pubmed: 30128552
RMD Open. 2015 Aug 15;1(Suppl 1):e000053
pubmed: 26557375
Arthritis Care Res (Hoboken). 2018 Sep;70(9):1416-1420
pubmed: 29193835
JAMA. 2018 Jul 17;320(3):231-232
pubmed: 29800120
Perm J. 2016 Fall;20(4):15-151
pubmed: 27479952
PLoS One. 2016 May 02;11(5):e0154515
pubmed: 27135409
Arthritis Care Res (Hoboken). 2012 Jun;64(6):905-10
pubmed: 22275150
Health Aff (Millwood). 2018 Aug;37(8):1257-1264
pubmed: 30044651
J Law Med Ethics. 2001 Spring;29(1):13-27
pubmed: 11521267
Clin Rheumatol. 2014 Dec;33(12):1745-50
pubmed: 25178777
Eur Heart J. 2014 Aug 7;35(30):2010-20
pubmed: 24126876
Arthritis Rheumatol. 2014 May;66(5):1363-71
pubmed: 24782192
BMC Musculoskelet Disord. 2018 Sep 5;19(1):317
pubmed: 30185185
J Health Serv Res Policy. 2011 Apr;16(2):108-17
pubmed: 20819913
J Rheumatol. 2020 Jan;47(1):42-49
pubmed: 30877217
Clin Rheumatol. 2015 Aug;34(8):1397-405
pubmed: 25185731
Arthritis Rheumatol. 2016 Mar;68(3):679-89
pubmed: 26473967
Arthritis Rheum. 2012 May;64(5):1407-11
pubmed: 22139851
Arthritis Res Ther. 2014 Aug 06;16(4):R164
pubmed: 25099160
Ethn Dis. 2016 Apr 21;26(2):181-90
pubmed: 27103768
BMJ Open. 2013 May 14;3(5):
pubmed: 23676796
Arthritis Res Ther. 2016 Nov 16;18(1):265
pubmed: 27852321

Auteurs

Jessica A Walsh (JA)

University of Utah School of Medicine, Salt Lake City, Utah.

Martin Rozycki (M)

HVH Precision Analytics, Wayne, Pennsylvania.

Esther Yi (E)

The University of Texas at Austin, Austin.
Baylor Scott and White Health, Temple, Texas.

Yujin Park (Y)

Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH